Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice
Duration: 48 months, Funding volume: € 799,570
Protecting vascular barrier function across discipline and disease boundaries
Duration: 54 months, Funding volume: € 366,000
Deciphering genomic aberrations in rare skin cancers to find mechanism-based treatment strategies
Duration: 82 months, Funding volume: € 972,100